ADALIMUMAB

Clinical Indication

Moderate rheumatoid arthritis.

Comments

In line with NICE TA715

Date of classification

October 2021

Review date

October 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).